2022 R&D Spend: In 2022, Teva Pharmaceuticals spent $838 million on R&D, a 13.34 percent decrease from the $967 million the company spent on R&D in 2021
Unlike synthetic growth hormone injections, which flood your system with external hormones, Ipamorelin signals your pituitary gland to produce more of your own
HOW SUPPLIED/STORAGE AND HANDLING How Supplied TOUJEO (insulin glargine) injection, 300 units/mL (U-300), is a clear and colorless solution and is available as: Needles are not included in the packs of TOUJEO SoloStar or TOUJEO Max SoloStar single-patient-use prefilled pen

By leveraging berberine's documented ability to influence cellular energy regulation and glucose metabolism, this botanical product is positioned as an accessible, scientifically backed holistic alternative to naturally manage blood sugar levels and support sustainable wellness without relying solely on synthetic pharmaceuticals In December 2025, Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the results of two Phase III clinical studies of Mazdutide, the world's first approved glucagon (GCG)/glucagon-like peptide-1 (GLP-1) dual receptor agonist, in Chinese adults with type 2 diabetes (T2D) (DREAMS-1, DREAMS-2) have been published back-to-back in Nature as Accelerated Article Previews (AAP)
Montero, A., Sparks, G., Presiado, M
He L, Li Y, Zeng N, Stiles BL